Millennium Molecular Pathology Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-05-2024
- Paid Up Capital ₹ 0.10 M
as on 18-05-2024
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue -0.10%
(FY 2017)
- Profit 18.87%
(FY 2017)
- Ebitda 88.35%
(FY 2017)
- Net Worth -14.22%
(FY 2017)
- Total Assets -13.93%
(FY 2017)
About Millennium Molecular Pathology
- CIN/LLPIN
U85110PN2007PTC131003
- Company No.
131003
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Nov 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Millennium Molecular Pathology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjali Bordawekar  | Director | 02-Mar-2016 | Current |
| Shalaka Bordawekar | Director | 19-Nov-2007 | Current |
Financial Performance of Millennium Molecular Pathology.
Millennium Molecular Pathology Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 0.1% decrease. The company also saw a substantial improvement in profitability, with a 18.87% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Millennium Molecular Pathology?
In 2017, Millennium Molecular Pathology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Millennium Molecular Pathology?
Unlock and access historical data on people associated with Millennium Molecular Pathology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Millennium Molecular Pathology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Millennium Molecular Pathology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
